Moleculin Biotech, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Moleculin Biotech, Inc. (MBRX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 12.70 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 12.70M shares, a 1170.00% increase year-over-year.
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 10.00M shares, a 1566.67% increase year-over-year.
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 85.70M shares, a 1685.42% increase year-over-year.
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.00M shares, a 37.50% decline year-over-year.
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.60M shares, a 550.00% increase from fiscal 2024.
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 400.00K shares, a 20.00% decline from fiscal 2023.
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 500.00K shares, a 25.00% increase from fiscal 2022.
- Moleculin Biotech, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 400.00K shares, a 90.70% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 12.70M shares 10-Q · filed 2026-08-13 | 11.30M shares 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | 10.00M shares 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | 2.60M shares 10-K · filed 2026-03-18 | |||||||
| 2025-09-30 | 85.70M shares 10-Q · filed 2025-11-13 | 41.70M shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 1.00M shares 10-Q · filed 2026-08-13 | 24.50M shares 10-Q · filed 2025-08-12 | 700.00K shares 10-Q · filed 2026-08-13 | 19.30M shares 10-Q · filed 2025-08-12 | ||||
| 2025-03-31 | 600.00K shares 10-Q · filed 2026-05-14 | 14.00M shares 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | 400.00K shares 10-K · filed 2026-03-18 | 4.30M shares 10-K · filed 2025-03-21 | ||||||
| 2024-09-30 | 4.80M shares 10-Q · filed 2025-11-13 | 2.70M shares 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | 1.60M shares 10-Q · filed 2025-08-12 | 1.60M shares 10-Q · filed 2025-08-12 | 400.00K shares 10-Q · filed 2024-08-13 | |||||
| 2024-03-31 | 1.70M shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 500.00K shares 10-K · filed 2025-03-21 | |||||||
| 2023-09-30 | 600.00K shares 10-Q · filed 2024-11-08 | 8.50M shares 10-Q · filed 2023-11-13 | 500.00K shares 10-Q · filed 2024-11-08 | 7.00M shares 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | 6.40M shares 10-Q · filed 2023-08-10 | 6.30M shares 10-Q · filed 2023-08-10 | ||||||
| 2023-03-31 | 400.00K shares 10-Q · filed 2024-05-10 | 6.20M shares 10-Q · filed 2023-05-10 | ||||||
| 2022-12-31 | 400.00K shares 10-K · filed 2024-03-22 | 5.50M shares 10-K · filed 2023-03-22 | ||||||
| 2022-09-30 | 6.00M shares 10-Q · filed 2023-11-13 | 5.20M shares 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | 4.90M shares 10-Q · filed 2023-08-10 | 4.80M shares 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | 4.80M shares 10-Q · filed 2023-05-10 | |||||||
| 2021-12-31 | 4.30M shares 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | 4.50M shares 10-Q · filed 2022-11-10 | 4.10M shares 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | 4.00M shares 10-Q · filed 2022-08-12 | 3.90M shares 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | 3.80M shares 10-Q · filed 2022-05-11 | |||||||
| 2020-12-31 | 3.60M shares 10-K · filed 2022-03-24 | |||||||
| 2020-09-30 | 3.80M shares 10-Q · filed 2021-11-10 | 22.90M shares 10-Q · filed 2020-11-12 | 3.40M shares 10-Q · filed 2021-11-10 | 20.80M shares 10-Q · filed 2020-11-12 | ||||
| 2020-06-30 | 3.50M shares 10-Q · filed 2021-08-11 | 21.20M shares 10-Q · filed 2020-08-12 | 3.30M shares 10-Q · filed 2021-08-11 | 19.80M shares 10-Q · filed 2020-08-12 | ||||
| 2020-03-31 | 3.10M shares 10-Q · filed 2021-05-12 | 18.40M shares 10-Q · filed 2020-05-11 | ||||||
| 2019-12-31 | 2.00M shares 10-K · filed 2021-03-24 | 12.20M shares 10-K · filed 2020-03-19 | ||||||
| 2019-09-30 | 14.70M shares 10-Q · filed 2020-11-12 | 11.30M shares 10-Q · filed 2020-11-12 | ||||||
| 2019-06-30 | 12.30M shares 10-Q · filed 2020-08-12 | 9.50M shares 10-Q · filed 2020-08-12 | 13.43M shares 10-Q · filed 2019-08-16 | |||||
| 2019-03-31 | 6.70M shares 10-Q · filed 2020-05-11 | 9.55M shares 10-Q · filed 2019-05-13 | ||||||
| 2018-12-31 | 5.40M shares 10-K · filed 2020-03-19 | |||||||
| 2018-09-30 | 6.50M shares 10-Q · filed 2019-11-12 | 5.00M shares 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | 6.54M shares 10-Q · filed 2019-08-16 | |||||||
| 2018-03-31 | 4.52M shares 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |